Kalina Ignatova

KI

Statistics

Publications

1

Citations

39

H-Index

1

Active since

2022

Kalina Ignatova is an author at Apellis Pharmaceuticals (United States) specializing in open-label trials, hematology, and complement-mediated damage.

Publications per year

2022–2022

1

Publications

1